Dr. Thomas Lönngren, Strategic Advisor NDA Group and former head of the EMA, has been invited to speak in the session ‘Ensuring Transparency and Drug Value’ at the Boston CEO conference, Four Seasons Boston on May 30th.
Boston CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world’s leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.
To read more about the event click here.
Dr. Thomas Lönngren, Strategic Advisor NDA Group